Use of a PPAR-delta agonist for treating muscle atrophy
US9487493B2 · kind B2 · utility
9Cited by
9References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 5, 2014 |
| Grant date | Nov 8, 2016 |
| Priority date | — |
| Expiry date | Sep 5, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/096
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for treating muscle atrophy by administering a PPARδ agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.